BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7216882)

  • 1. Drug selection and use in mastitis: systemic vs local therapy.
    Ziv G
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1109-15. PubMed ID: 7216882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder.
    Ehinger AM; Schmidt H; Kietzmann M
    Vet J; 2006 Jul; 172(1):147-53. PubMed ID: 16772139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of various forms of bovine mastitis with consideration of udder pathology and the pharmacokinetics of appropriate drugs: a review.
    du Preez JH
    J S Afr Vet Assoc; 1988 Sep; 59(3):161-7. PubMed ID: 3058977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis.
    Gehring R; Smith GW
    J Vet Pharmacol Ther; 2006 Aug; 29(4):237-41. PubMed ID: 16846460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic aspects of mastitis therapy].
    Ehinger AM; Kietzmann M
    Berl Munch Tierarztl Wochenschr; 1998 Sep; 111(9):337-43. PubMed ID: 9789371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo studies on lysosubtilin. 3. Efficacy for treatment of mastitis and superficial lesions of the udder and teats in cows.
    Biziulevichius GA; Lukauskas K
    Vet Res; 1998; 29(5):441-56. PubMed ID: 9779557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative randomized field trial on intramammary and intramuscular dry cow antibiotic treatment of subclinical Staphylococcus aureus mastitis in dairy cows.
    Shpigel NY; Kass PH; Saran A
    J Vet Med A Physiol Pathol Clin Med; 2006 Oct; 53(8):418-22. PubMed ID: 16970632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of systemic or intramammary antimicrobial treatment of bovine subclinical mastitis during lactation.
    Sandgren CH; Waller KP; Emanuelson U
    Vet J; 2008 Jan; 175(1):108-17. PubMed ID: 17320434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the concentration-time relationship in milk from cattle administered an intramammary drug.
    Whittem T; Whittem JH; Constable PD
    J Vet Pharmacol Ther; 2012 Oct; 35(5):460-71. PubMed ID: 22150507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spiramycin and the antibacterial therapy of mastitis].
    Verheijden JH; Vecht U; van Leeuwen W; van Miert AS
    Tijdschr Diergeneeskd; 1984 Jul; 109(13):554-6. PubMed ID: 6464000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue concentration of intrauterine and intravenously administered amoxicillin in the isolated hemoperfused bovine uterus model and in healthy cows.
    Braun M; Zerbe H; Kietzmann M
    Berl Munch Tierarztl Wochenschr; 2009; 122(1-2):51-7. PubMed ID: 19226935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical pharmacokinetic aspects of mastitis therapy--1: parenteral treatment.
    Ziv G
    Vet Med Small Anim Clin; 1980 Feb; 75(2):277-90. PubMed ID: 6899639
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of bovine mastitis during the dry period and development of intramammary drug formulations].
    Donev B; Dancheva L
    Vet Med Nauki; 1982; 19(4):75-82. PubMed ID: 6758318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between results of in vitro susceptibility tests and outcomes following treatment with pirlimycin hydrochloride in cows with subclinical mastitis associated with gram-positive pathogens.
    Apparao D; Oliveira L; Ruegg PL
    J Am Vet Med Assoc; 2009 Jun; 234(11):1437-46. PubMed ID: 19480625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis.
    Morin DE; Shanks RD; McCoy GC
    J Am Vet Med Assoc; 1998 Sep; 213(5):676-84. PubMed ID: 9731263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The systemic therapy of clinical bovine mastitis.
    Giesecke WH
    J S Afr Vet Assoc; 1977 Dec; 48(4):289-91. PubMed ID: 599548
    [No Abstract]   [Full Text] [Related]  

  • 17. Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens.
    Lacasse P; Lauzon K; Diarra MS; Petitclerc D
    J Anim Sci; 2008 Mar; 86(13 Suppl):66-71. PubMed ID: 17565052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two regimens for the treatment of clinical bovine mastitis caused by bacteria sensitive to penicillin.
    Waage S
    Vet Rec; 1997 Dec; 141(24):616-20. PubMed ID: 9447674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commensal bacilli inhibitory to mastitis pathogens isolated from the udder microbiota of healthy cows.
    Al-Qumber M; Tagg JR
    J Appl Microbiol; 2006 Nov; 101(5):1152-60. PubMed ID: 17040239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial drugs used against mastitis in cattle by the systemic route.
    MacDiarmid SC
    N Z Vet J; 1978 Dec; 26(12):290-5. PubMed ID: 284237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.